Buy Celgene Stock | CELG Stock Price & Latest News | Public
CELG

Celgene

$0.00 (0.00%)Today

    About CELG

    Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment option...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    3.04
    2.03
    1.01
    0
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    $2.89

    Actual EPS
    Q3 2020

    Stats

    Market Cap$77,03B
    Volume
    Price-to-Earnings Ratio13.32
    Dividend Rate
    Dividend Yield
    1 Year High$110.70
    1 Year Low$58.59
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app